Compare Fulford India with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs SUVEN LIFESCIENCES - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA SUVEN LIFESCIENCES FULFORD INDIA/
SUVEN LIFESCIENCES
 
P/E (TTM) x 398.8 19.9 2,003.2% View Chart
P/BV x 6.2 4.0 154.1% View Chart
Dividend Yield % 0.1 0.5 16.2%  

Financials

 FULFORD INDIA   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
SUVEN LIFESCIENCES
Mar-19
FULFORD INDIA/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs942338 278.9%   
Low Rs450169 265.6%   
Sales per share (Unadj.) Rs691.452.1 1,326.3%  
Earnings per share (Unadj.) Rs11.56.8 167.8%  
Cash flow per share (Unadj.) Rs15.48.6 179.2%  
Dividends per share (Unadj.) Rs2.001.50 133.3%  
Dividend yield (eoy) %0.30.6 48.6%  
Book value per share (Unadj.) Rs380.065.3 582.0%  
Shares outstanding (eoy) m3.90127.28 3.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.9 20.7%   
Avg P/E ratio x60.737.1 163.6%  
P/CF ratio (eoy) x45.329.6 153.2%  
Price / Book Value ratio x1.83.9 47.2%  
Dividend payout %17.422.0 79.5%   
Avg Mkt Cap Rs m2,71432,272 8.4%   
No. of employees `0000.41.1 41.0%   
Total wages/salary Rs m505661 76.4%   
Avg. sales/employee Rs Th6,073.06,132.2 99.0%   
Avg. wages/employee Rs Th1,137.4611.1 186.1%   
Avg. net profit/employee Rs Th100.7803.5 12.5%   
INCOME DATA
Net Sales Rs m2,6966,635 40.6%  
Other income Rs m125242 51.8%   
Total revenues Rs m2,8226,877 41.0%   
Gross profit Rs m-461,604 -2.9%  
Depreciation Rs m15221 6.9%   
Interest Rs m1038 25.2%   
Profit before tax Rs m541,587 3.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m10718 1.3%   
Profit after tax Rs m45869 5.1%  
Gross profit margin %-1.724.2 -7.1%  
Effective tax rate %17.745.2 39.1%   
Net profit margin %1.713.1 12.7%  
BALANCE SHEET DATA
Current assets Rs m1,7386,232 27.9%   
Current liabilities Rs m5451,490 36.6%   
Net working cap to sales %44.371.5 61.9%  
Current ratio x3.24.2 76.3%  
Inventory Days Days4886 56.1%  
Debtors Days Days483 5.2%  
Net fixed assets Rs m124,043 0.3%   
Share capital Rs m39127 30.6%   
"Free" reserves Rs m1,4438,183 17.6%   
Net worth Rs m1,4828,310 17.8%   
Long term debt Rs m018 0.0%   
Total assets Rs m2,07710,389 20.0%  
Interest coverage x6.743.1 15.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.6 203.3%   
Return on assets %2.68.7 29.9%  
Return on equity %3.010.5 28.8%  
Return on capital %4.319.5 22.1%  
Exports to sales %00-   
Imports to sales %24.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659NA-   
Fx inflow Rs m175,622 0.3%   
Fx outflow Rs m6731,799 37.4%   
Net fx Rs m-6563,822 -17.2%   
CASH FLOW
From Operations Rs m90356 25.3%  
From Investments Rs m105-279 -37.5%  
From Financial Activity Rs m-14-225 6.3%  
Net Cashflow Rs m181-148 -121.8%  

Share Holding

Indian Promoters % 0.0 63.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 0.0 -  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 36.5 58.1%  
Shareholders   4,783 37,287 12.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  FDC LTD.  PROCTER & GAMBLE HEALTH  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Witness Selling, Key Q2FY20 Results, and Top Cues in Focus Today(Pre-Open)

India share markets ended their day deep in the red yesterday. At the closing bell yesterday, the BSE Sensex stood lower by 334 points (down 0.9%).

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS